Using laxatives and purging (as is sometimes seen in cases of bulimia nervosa) can lead to poor quality nutrient intake
Compared with normal hepatic function, the estimated ratio of the mean AUC 0 was 0.99 (0.891.11) in mild impairment, 1.01 (0.911.12) in moderate impairment and 1.11 (0.961.30) in severe impairment
Patients taking tirzepatide in both trials had a 1617% reduction in body weight, along with improvements in OSA-specific hypoxic burden, and high sensitivity C-reactive protein (a biomarker of systemic inflammation and cardiovascular risk) [113, 114]
Neither outcome is acceptable when the math is this straightforward
In Phase 2 obesity trials, retatrutide produced approximately 24% mean body-weight reduction at 48 weeks at the 12 mg dose the largest weight-loss effect reported for any GLP-1-class compound to date
There may be alternative techniques, sites, or approaches that could improve your experience